טוען...
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
Patients with systemic immunoglobulin light chain amyloidosis (AL) with no evidence of cardiac involvement by consensus criteria have excellent survival, but 20% will die within 5 years of diagnosis and prognostic factors remain poorly characterised. We report the outcomes of 378 prospectively follo...
שמור ב:
| הוצא לאור ב: | Haematologica |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Ferrata Storti Foundation
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7193493/ https://ncbi.nlm.nih.gov/pubmed/31399529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.217695 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|